Endocervical Adenocarcinoma as a Secondary Malignancy in a Patient Treated for Non-Hodgkin's Lymphoma: A Case Report with Review of Literature

被引：0

作者：

Dhull, Garima ^{[1
]}

Bhardwaj, Minakshi ^{[1
]}

Gupta, Stuti ^{[2
]}

Pujani, Mukta ^{[1
]}

Chauhan, Varsha ^{[1
]}

Garg, Neha ^{[1
]}

Sharma, J. C. ^{[2
]}

Malik, Sunita ^{[2
]}

机构：

[1] Employees State Insurance Corp Med Coll & Hosp, Dept Pathol, NIT 3, Faridabad 121012, Haryana, India

[2] Employees State Insurance Corp Med Coll & Hosp, Dept Obstet & Gynecol, Faridabad, Haryana, India

来源：

INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2025年

关键词：

secondary malignancy; NHL; endocervical adenocarcinoma; gynecological malignancy; case report; 2ND MALIGNANCIES; RISK;

D O I：

10.1055/s-0045-1810067

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Secondary malignancy can arise in patients with non-Hodgkin's lymphoma (NHL) on long follow-up. The risk of developing secondary malignancies is increased in NHL survivors, as compared to normal population and varies according to age, gender, and treatment modality. The nature of solid organ malignancy in order of frequency includes lung cancer followed by prostate, bladder, colon, breast, etc. Gynecological malignancy occurring in an NHL survivor is an extremely rare phenomenon with a low observed/expected ratio (0.89-0.93) as compared to other solid tumors. We hereby report a case of endocervical adenocarcinoma arising in a 51-year-old female patient who was a known treated case of NHL. This case highlights the fact that chemotherapy-induced atypia may mimic malignancy as well as the rare occurrence of gynecological cancers as a secondary malignancy in patients with NHL.

引用

页数：3

共 7 条

[1] Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis [J].